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In	the	past	few	years	it	has	become	clear	that	cancer	
research	must	not	only	focus	on	the	malignant	cell	itself	
but	also	the	microenvironment.	The	cell-cell	contact	of	
tumor	cells	with	stromal	cells	is	crucial	for	hallmarks	of	
malignant	cells	like	proliferation,	migration,	metastases	
development,	and	survival.	Additionally,	adhesion	of	
tumor	cells	 to	stromal	cells	conveys	drug	resistance	
and	survival	to	chemotherapy.	This	has	been	shown	for	
a	broad	variety	of	entities,	such	as	multiple	myeloma,	
acute	and	chronic	leukaemia,	lymphoma,	lung	cancer	
and	breast	cancer	[for	review	see	1	and	2].	This	is	due	to	
altered	signalling	pathway	activation	upon	cell	adhesion.	
For	example,	Chatterjee	et	al.	[3]	have	demonstrated	that	
in	the	presence	of	bone	marrow	stromal	cells,	myeloma	
cells	become	independent	of	the	IL-6/gp130/STAT3	—	
pathway.	Furthermore,	we	have	previously	shown	that	a	
primary	drug	resistance	mechanism	is	mediated	by	the	
HMG-CoA/GG-PP/Rho/Rho-kinase	pathway,	is	relayed	
by	cell	adhesion,	and	can	be	therapeutically	 targeted	
[4].	Interestingly,	drug	resistance	and	activation	of	the	
mentioned	pathway	was	strongly	dependent	on	direct	
cell-cell	contact,	whereas	involvement	of	soluble	factors	
could	be	excluded	[4].	Many	groups	have	focused	their	
research	on	adhesion	to	extra	cellular	matrix	proteins	
like	 fibronectin	as	model	 for	micro	environmental	ef-
fects.	The	biological	effects	on	cancer	cells,	however,	
greatly	differ	between	the	use	of	fibronectin	or	that	of	
viable	stromal	cells	with	their	large	spectrum	of	interact-
ing	membrane	receptors	and	ligands	[4].	In	conclusion,	
signal	transduction	research	of	adherent	malignant	cells	
includes	the	elucidation	of	cell-cell	contact	mediated	
signals.	The	coculture	of	malignant	cells	with	stromal	
cells	 is	actually	a	 rather	straightforward	method,	but	
signal	 transduction	research	on	these	cells	 frequently	
becomes	cumbersome,	or	even	impossible,	due	to	dif-
ficulties	with	separation	of	the	cells,	detachment	of	the	
cells,	or	medium	competition.
In	this	article	we	describe	the	technical	approach	
in	cell-cell	contact	mediated	signal	transduction	 re-
search	using	the	established	model	of	primary	long-
term	bone	marrow	stromal	cell	 cultures	 [5,	6]	and	
multiple	myeloma	cells.	Furthermore,	we	present	an	
alternative	method	using	the	HS-5	human	bone	mar-
row	stromal	cell	 line,	which	seems	to	be	superior	 in	
terms	of	feasibility	and	reproducibility.
MATERIALS AND METHODS
Cells	were	grown	 in	RPMI	1640	medium	(Boeh-
ringer,	Germany)	containing	10%	heat	—	inactivated	
fetal	 calf	 serum	 (FCS;	Boehringer)	 in	a	humidified	
atmosphere	(37.5	°C;	5%	CO2).
Primary bone marrow stromal cells. The	genera-
tion	of	a	confluent	layer	of	primary	bone	marrow	stro-
mal	cells	was	performed	according	to	the	protocol	of	
Lokhorst	and	colleagues	[5,	6].	Mononuclear	cells	were	
separated	from	bone	marrow	aspirates	by	Ficoll-Paque	
(Amersham	Pharmacia,	Sweden)	using	LeucoSep	
(Greiner,	Germany)	tubes.	Bone	marrow	mononuclear	
cells	(BMMC)	were	washed	twice	with	2%	FCS-PBS	and	
seeded	at	2	x	106	cells	per	millilitre	in	plastic	flasks	or	
well	plates	using	medium	with	20%	FCS.	After	one	week	
half	of	the	supernatant	was	discarded	and	renewed	with	
fresh	medium.	The	procedure	was	repeated	weekly	until	
a	confluent	layer	of	stromal	cells	was	grown.	In	average	
it	took	about	6–9	weeks.
After	 this	 time	complete	medium	was	 removed	
weekly	 to	 clear	 the	 culture	 from	 remaining	 round	
cells.	In	our	experience	the	stromal	culture	could	be	
split	using	tyrypsin	two	times	to	expand	the	material.	
Most	cultures	showed	no	further	growth	after	the	third	
passage.
Co-culture of primary bone marrow stromal 
cells and multiple myeloma cells. Multiple	myeloma	
cells	(NCI-H929,	OPM-2,	U266,	RPMI-8226	cell	lines)	
were	seeded	at	105/ml	on	the	stromal	cell	layer.	Adher-
ence	was	observed	after	15	to	30	minutes.	Longer	co-
incubation	did	not	further	increase	adherence.	There-
fore,	1h	after	myeloma	cells	were	seeded	cytotoxic	
compounds,	like	melphalan,	treosulfan,	bortezomib,	
dexamethasone,	or	doxorubicine,	were	added.	After	
48	to	72	h	myeloma	cells	were	detached	by	pipetting	
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vigorously	using	a	1000	µl	pipette.	All	myeloma	cells	
should	be	removed	(the	 firmly	adherent	cells	are	of	
major	interest).	This	has	to	be	checked	by	microscopy.	
On	the	other	hand,	stromal	cells	may	not	be	detached	
because	these	very	large	cells	cause	clumps	and	make	
further	processing	of	the	material	 impossible.	Avoid	
use	of	cell	scrapers	or	trypsin,	as	detached	cells	should	
be	intact	and	alive.	Staining	with	trypan	blue	checked	
cell	shape	and	membrane	integrity.
Co-cultures	with	primary	 human	bone	marrow	
stromal	cells	have	several	disadvantages:	firstly,	the	
availability	of	bone	marrow	aspirates	is	limited,	even	
at	specialized	centres.	The	procedure	of	bone	marrow	
aspiration	 is	painful	 and	 therefore	ethical	 approval	
and	patient’s	consent	must	be	obtained.	Many	pa-
tients	have	been	 treated	with	cytotoxic	compounds	
and	 almost	 all	 donors	 have	 hematological	 (bone	
marrow)	disease.	There	 is	 increasing	evidence	 that	
bone	marrow	stromal	cells	are	crucially	 involved	 in	
the	pathophysiology	of	these	diseases	and	therefore	
may	display	an	altered	phenotype	compared	to	“nor-
mal”	stromal	cells.	Additionally,	a	single	bone	marrow	
probe	allows	performance	of	a	very	 little	number	of	
experiments.	Therefore,	 investigations	on	myeloma	
cells	have	to	be	performed	using	stromal	cells	from	
different	donors.	Thus,	comparability	of	experimental	
series	 is	 significantly	hampered.	Secondly,	 it	 takes	
several	weeks	until	a	confluent	layer	is	grown	with	a	
high	risk	of	bacterial	contamination	and	herewith	loss	
of	the	valuable	stromal	cell	sample.
Thirdly,	 the	mechanical	detachment	of	myeloma	
cells	from	the	stromal	layer	by	pipetting	and	scratch-
ing	injures	the	cells	and	e.g.	increases	the	annexin	V	
positivity	and	herewith	falsifies	the	results.	Addition-
ally,	signal	transduction	research	on	primary	stromal	
cells	itself	is	very	difficult	due	to	the	low	availability	as	
well	as	the	large	cell	volume	that	interferes	with	flow	
cytometry	analyses.
We	attempted	 to	 facilitate	 the	work	with	primary	
bone	marrow	stromal	cells	and	have	therefore	estab-
lished	a	protocol	using	the	bone	marrow	stromal	cell	
line	HS-5.	This	method	provides	easy	handling,	good	
reproducibility,	and	low	risk	of	false	results.
Co-culture of HS-5 bone marrow stromal 
cells and multiple myeloma cells. HS-5	 cells	
were	 obtained	 from	 the	 American	 Type	Culture	
Collection	 (Rockville,	USA).	Three	days	before	 the	
co-culture	HS-5	cells	were	 trypsinized	 in	 the	 cul-
ture	 flask	with	8	ml	Trypsin	 (Trypsin-EDTA,	Sigma,	
Germany),	washed	 twice,	and	 then	 resuspended	 in	
20	ml	RPMI-1640/10%FCS.	HS-5	were	seeded	in	6-,	
12-	or	24-well	plates	at	a	concentration	of	5x104/ml	for	
3	days	until	a	confluent	layer	has	developed.	Multiple	
myeloma	cells	 (NCI-H929,	RPMI-8226,	OPM-2	and	
U266)	were	added	to	the	HS-5	layer	at	a	concentra-
tion	of	1.5x105/ml	for	a	two-day	incubation	period	or	
at	105/ml	for	 incubation	over	4	days.	After	adhesion	
(30	min)	cytotoxic	drugs	and	pathway	modulators	were	
added.	On	day	2	(or	4),	co-cultures	were	checked	by	
microscopy	 (Fig	1,	a).	All	cells	were	detached	 from	
the	well	using	a	cell	scraper,	which	can	be	very	easily	
and	gently	done.	This	procedure	does	not	affect	cell	
shape	(microscopy),	membrane	integrity	(propidium	
iodide,	trypan	blue)	and	asymmetry	of	the	membrane	
(annexin	V).	Myeloma	and	stromal	cells	are	suspended	
in	medium	and	can	be	further	processed	for	biological	
or	signal	transduction	assays.	For	example,	Fig.	1,	b,	
shows	that	co-cultured	cells	can	be	easily	separated	
by	 flow	cytometry	after	CD38-FITC	staining.	Using	
a	second	or	 third	 fluorescent,	characteristics	of	 the	
myeloma	cells	can	be	determined.	Here	cell	death	
upon	melphalan	treatment	determined	by	propidium	
iodide	uptake	 is	shown	(see	Fig.1,	b).	Furthermore,	
monoculture	of	myeloma	cells	may	be	compared	to	
co-culture	 regarding	melphalan	 induced	cell	death.	
Fig.	1,	c,	demonstrates	that	co-cultured	myeloma	cells	
are	much	less	susceptible	to	melphalan.	Additionally,	
myeloma	cells	can	be	purified	by	magnetic	cell	sorting	
(anti-CD138-MACS,	Miltenyi	Biotec,	Germany)	and	
expression	of	pathway	proteins	can	be	determined	
by	western	blotting,	as	described	[7].	Fig.	1,	d,	shows	
unaltered	protein	expression	 levels	of	antiapoptotic	
proteins	 (Bcl-2,	Bcl-XL)	 and	 important	 signalling	
kinases	 (Erk-2,	Akt,	PKCα).	For	 further	 results	see	
[4].	Of	note,	we	have	shown	that	—	at	least	regarding	
cell	adhesion	mediated	drug	resistance	—	HS-5	cells	
display	comparable	results	with	primary	bone	marrow	
stromal	cells	[4].
DISCuSSION AND TROubLE SHOOTING
An	 important	question	was	whether	 apoptotic/	
necrotic	cells	still	express	sufficient	amounts	of	sur-
face	antigens	to	ensure	proper	separation	of	myeloma	
from	 the	bone	marrow	stromal	HS-5	cells.	For	 this	
reason	we	always	performed	control	 experiments	
with	myeloma	cell	monocultures	to	exclude	a	possible	
CD38	negative	second	myeloma	population.	Fig.	2,	a	
and	2,	b, demonstrate	that	at	higher	concentrations	
of	cytotoxic	compounds	expression	levels	of	certain	
surface	antigens	like	CD38	are	lowered.	Even	at	high	
concentrations,	however,	myeloma	cells	do	not	com-
pletely	 lose	a	detectable	CD38	expression,	 thus	no	
CD38	negative	second	population	of	dead	myeloma	
cells	could	be	misinterpreted	as	HS-5	cells.
Furthermore,	despite	a	certain	reduction	of	surface	
expression	of	CD38,	myeloma	cells	can	be	clearly	
separated	from	HS-5	stromal	cells.	Interestingly,	some	
necrotic	myeloma	cells	 just	 resolve,	since	 the	 ratio	
between	myeloma	and	stromal	cells	declines	upon	
chemotherapy	treatment	(Fig.	2,	c).	However,	these	
cells	do	not	perturb	our	assay.	Occasionally,	myeloma	
cells	do	not	adhere	to	HS-5	cells	properly.	This	is	due	
to	a	false	concentration	of	myeloma	cells	(above	2	x	
105/ml)	or	a	too	extensive	use	of	trypsin.	One	limitation	
of	this	model	is	the	fact	that	HS-5	are	quickly	prolifer-
ating	cells	(doubling	time	72	h).	Experiments,	which	
depend	on	incubation	periods	longer	than	four	days	
are	difficult	to	perform.	Primary	seeding	concentration	
has	to	be	reduced	in	such	cases,	but	below	a	certain	
threshold	adhesion	 is	no	 longer	guaranteed.	 In	ac-
14	 Experimental	Oncology	28,	12–15,	2006	(March)
cordance	in	some	experiments	more	myeloma	cells	
were	PI	positive	 in	 the	coculture	control	 than	 in	 the	
monoculture	control.	This	was	the	result	of	inadequate	
HS-5	cell	numbers.	Because	HS-5	cells	turn	medium	
acidic	very	quickly,	 their	number	should	not	be	 too	
high.	This	depends	on	 the	used	culture	 flask	but	 in	
general	the	amount	of	HS-5	cells	may	never	exceed	
the	space	they	have	to	adhere.	
Outside-in	signaling	is	not	only	mediated	by	soluble	
ligands,	but	as	well	by	adhesion	molecules	that	medi-
ate	direct	interaction	with	other	cells.	Cancer	cells	are	
characterized	by	certain	organ	preferences	in	terms	of	
primary	growth	and	as	well	in	terms	of	metastases.
Circulating	 tumor	 cells	 anchor	 to,	 survive	 and	
proliferate	 in	 these	 target	 organs	whereas	 other	
organs	 are	 spared.	Convincing	 examples	 are	 the	
adrenal	gland	metastases	of	 the	—	neuroendocrine	
differentiated	—	small	cell	lung	cancer,	or	the	diffuse	
infiltration	of	the	entire	skeleton	by	multiple	myeloma	
cells	sparing	almost	all	other	tissues.	Cell-cell	contact	
mediated	signalling	 research	depends	on	coculture	
experiments.	We	have	described	the	frequently	used	
method	of	primary	 long	 term	bone	marrow	stromal	
cell	culture,	because	in	most	publications	important	
details	are	not	given,	which	are	necessary	for	repro-
duction.	This	method	is	limited	by	the	large	size	of	the	
stromal	cells	and	difficulties	in	detachment,	the	pre-
requisite	for	further	signalling	research.	We	therefore	
have	developed	a	method	using	immortalized	human	
bone	marrow	stromal	cells,	which	has	many	practical	
advantages.	Due	to	the	high	proliferation	rate	of	the	
HS-5	cells	 this	method	displays	certain	 limitations	
Fig. 1. Co-culture	of	HS-5	bone	marrow	stromal	cells	and	NCI-H929	multiple	myeloma	cells.	a. Microscopic	evaluation	(original	
magnification	x	100,	unstained)	of	confluent	primary	bone	marrow	stromal	cells	(*)	and	adherent	NCI-H929	myeloma	cells	(°)	after	48	
h	treatment	with	20	µM	melphalan.	#	indicates	a	non	viable	myeloma	cell.	b.	Separation	of	NCI-H929	myeloma	cells	(CD38+)	and	bone	
marrow	stromal	cells	(CD38-)	by	flow	cytometry.	Propidium	iodide	(PI)	uptake	in	gated	myeloma	cells	after	48	h	of	20	µM	melphalan	
was	determined.	c.	Determination	of	cell	adhesion	mediated	drug	resistance.	
CD38+ myeloma cells	were	gated	after	48	h	of	30	µM	melphalan	in	monoculture	(NCI-H929)	or	co-culture	(NCI-H929/HS-5).	
Percent	of	propidium	iodide	(PI)	positive	cells	was	determined	by	flow	cytometry.	d.CD38+	NCI-H929	were	purified	by	magnetic	cell	
sorter	after	monoculture	(NCI-H929)	or	co-culture	(NCI-H929).	Expression	levels	of	antiapoptotic	proteins	and	signalling	kinases	
were	determined	by	western	blotting
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as	well,	but	with	the	described	protocol	reproducible	
and	 reliable	experiments	can	be	performed	easily	
and	quickly.	As	we	have	previously	shown	[4]	that	the	
biological	effects	induced	by	stromal	cell	adhesion	are	
similar	for	primary	stromal	cells	and	HS-5	cells,	both	
methods	can	be	used	alternatively	depending	on	the	
special	experimental	requirements.	
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ПЕРЕДАЧА СИГНАЛА, оПоСРЕДовАННАя  
МЕЖКЛЕТоЧНЫМИ вЗАИМоДЕйСТвИяМИ
Исследования роста опухолевых клеток in vitro не отражают многих факторов (взаимодействие клеток с окружающей 
средой, их адгезию к клеткам стромы), которые в свою очередь могут определять чувствительность опухоли к терапии. 
Методологически изучение клеточной адгезии часто бывает затруднено, так как разделение клеток является основой 
большинства методик по изучению передачи сигнала. Впервые описан альтернативный метод ко-культивирования клеток 
множественной миеломы с клетками стромы линии HS-5, полученных из клеток костного мозга. Приведено подробное 
описание, преимущества и недостатки этого метода с детальными техническими рекомендациями.
Ключевые слова: клеточная адгезия, клеточное взаимодействие, методология, клетки стромы, миелоидные клетки.
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Fig. 2. Stable	expression	of	surface	marker	CD38	on	myeloma	
cells	after	melphalan	treatment.	NCI-H929	myeloma	cells	were	
treated	for	48	h	with	20	µM	(a)	or	30	µM	(b)	melphalan	in	mono-
culture	(NCI-H929)	or	co-culture	(NCI-H929/HS-5)	and	CD38	
expression	was	determined	by	 flow	cytometry.	c.	NCI-H929	
myeloma	cells	were	treated	with	20	µM	melphalan	in	the	pres-
ence	of	HS-5	stromal	cells.	The	 relative	CD38+	population	 is	
decreased	in	comparison	with	untreated	control
